Table 2. Characteristics of PCOS case participants who contributed HRQOL data at 3-year follow-up (n=1381) and PCOS cases and controls who completed the preference survey (n=422).
| HRQOL sample n (% of 1381) | Preference sample n (% of 422) | |
|---|---|---|
| Numbers per treatment strata | ||
| Cases (localised prostate cancer) | ||
| Radical prostatectomy | 839 (46.3) | 64 (15.2) |
| External beam radiotherapy (EBRT) only | 106 (5.8) | 66 (15.6) |
| Androgen deprivation therapy (ADT) only | 37 (2.0) | 37 (8.8) |
| Combined EBRT and ADT | 136 (7.5) | 64 (15.2) |
| Low-dose rate brachytherapy | 56 (3.1) | 31 (7.3) |
| High-dose rate brachytherapy | 41 (2.3) | 29 (6.9) |
| Active surveillance | 166 (9.2) | 66 (15.6) |
| Controls (without prostate cancer) | 65 (15.4) | |
| Age-group at 3-year follow-up or preference survey | ||
| <55 | 64 (4.6) | 21 (5.0) |
| 55–59 | 186 (13.5) | 39 (9.2) |
| 60–64 | 342 (24.8) | 84 (19.9) |
| 65–69 | 442 (32.0) | 149 (35.3) |
| 70–74 | 347 (25.1) | 129 (30.6) |
| Mean (s.d.) age | 65.0 (5.7) | 65.9 (5.7) |
| Highest level of education | ||
| Less than high school certificate | 57 (4.1) | 20 (4.7) |
| Completed high school | 953 (69.0) | 290 (68.7) |
| University or college degree | 364 (26.4) | 110 (26.1) |
| Unknown | 7 (0.5) | 2 (0.5) |
| Marital status at diagnosis | ||
| Married or living as married | 1160 (84.0) | 350 (82.9) |
| Never married, divorced, separated or widowed | 217 (15.7) | 72 (17.1) |
| Missing | 4 (0.3) | 0 (0.0) |
| Self reported health 3 year after diagnosis | ||
| Poor | 66 (4.8) | 11 (3.1) |
| Fair | 176 (12.7) | 55 (15.4) |
| Good | 338 (24.5) | 98 (27.5) |
| Very good | 519 (37.6) | 126 (35.3) |
| Excellent | 275 (19.9) | 64 (17.9) |
| Missing | 7 (0.5) | 3 (17.9) |
| PSA level at diagnosis (ng ml −1 ) | ||
| <4.0 | 140 (10.1) | 35 (9.8) |
| 4.0–9.9 | 799 (57.9) | 163 (45.7) |
| 10.0–19.9 | 282 (20.4) | 87 (24.4) |
| 20+ | 129 (9.3) | 65 (18.2) |
| Missing | 31 (2.2) | 7 (2.0) |
| Gleason score at diagnosis | ||
| 2–5 | 135 (9.8) | 36 (10.1) |
| 6 | 651 (47.1) | 151 (42.3) |
| 7 | 465 (33.7) | 120 (33.6) |
| 8–9 | 114 (8.3) | 47 (13.2) |
| Missing | 16 (1.2) | 3 (0.8) |
| Median months between diagnosis and preferences survey (cases) | 46 (32–60) | |
| Median months between recruitment and preferences survey (controls) | 30 (27–50) | |
Abbreviations: HRQOL=health-related quality of life; PCOS=Prostate Cancer Outcomes Study;PSA=prostate specific antigen.